Loading data for SEER — first visit, this takes a few seconds.
Seer, Inc. (SEER)
NasdaqGS: SEER
· Real-Time Price · USD
1.98
-0.03 (-1.49%)
At close: Sep 01, 2026, 8:00 PM
1.93
-0.52%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
Seer, Inc. (SEER) Stock Price, Analysis & Data
No data available
| Bid | 1.43 |
| Market Cap | 107M |
| Revenue (ttm) | 14.2M |
| Net Income (ttm) | -68M |
| 1.52 | |
| -1.22 | |
| n/a | |
| -1.9 | |
| P/B (ttm) | 0.48 |
| P/S (ttm) | 7.56 |
| Earnings Date | Nov 5, 2026 |
| Ask | 1.99 |
| Volume | 155,366 |
| Avg. Volume (20D) | 1,057,341 |
| Open | 2.01 |
| Previous Close | 2.01 |
| Day's Range | 1.98 - 2.02 |
| 52-Week Range | 1.55 - 2.41 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About SEER
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a...
Industry Biotechnology
Sector Healthcare
IPO Date Dec 4, 2020
Employees 124
Stock Exchange NasdaqGS
Ticker Symbol SEER
Website https://seer.bio
Financial Performance
In 2025, Seer's revenue was 16.12M, an increase of 15.57% compared to the previous year's 13.95M. Earnings were -73.6M, a decrease of -15.01%.
Financial StatementsEarnings Surprise
Seer has released their quarterly earnings on Aug 11, 2026:
- Revenue of $2.71M misses estimates by $0, with -34.72% YoY decline.
- EPS of -0.31 misses estimates by -0.04, with 6.06% YoY growth.
Seer, Inc. is scheduled to release its earnings on Nov 5, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade


